Nosa Plugs AB (NOSA) Fair Value & Analysis
Healthcare · SE · Market cap 138M SEK
Fair value as of: Jun 24, 2026
Analysis
Nosa Plugs AB (NOSA) currently trades at kr 0.5230, while our model-based Fair Value estimate is kr 0.4700 — implying the stock looks roughly 10.1% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).
About the company
Nosa Plugs AB, a medical technology company, develops, manufactures, and sells intranasal breathing products in Sweden, Europe, North America, Oceania, and internationally. It offers NOSA smell training, a smell training medical device to improve the sense of smell for individuals with parosmia and hyposmia; NOSA odor control, which reduces bad odor; NOSA microbial control that reduces the exposure of viruses and bacteria by inhalation through the nose; NOSA Nozoil original, a moisturizing nasal spray for people suffering from dry nasal mucosa; and NOSA Cerevia, a nasal drug delivery platform for controlled administration of drugs. The company was incorporated in 2014 and is headquartered in Stockholm, Sweden.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Nosa Plugs AB (NOSA) undervalued?
What is the fair value of NOSA?
What is the quality score of NOSA?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.